Marfan Database (second edition): software and database for the analysis of mutations in the human FBN1 gene

Fibrillin is the major component of extracellular microfibrils. Mutations in the fibrillin gene on chromosome 15 (FBN1) were described at first in the heritable connective tissue disorder, Marfan syndrome (MFS). More recently, FBN1 has also been shown to harbor mutations related to a spectrum of conditions phenotypically related to MFS. These mutations are private, essentially missense, generally non-recurrent and widely distributed throughout the gene. To date no clear genotype/phenotype relationship has been observed excepted for the localization of neonatal mutations in a cluster between exons 24 and 32. The second version of the computerized Marfan database contains 89 entries. The software has been modified to accomodate new functions and routines.

[1]  E. Haan,et al.  Characterisation of four novel fibrillin-1 (FBN1) mutations in Marfan syndrome. , 1996, Journal of Medical Genetics.

[2]  P. Byers,et al.  Delineation of the Marfan phenotype associated with mutations in exons 23-32 of the FBN1 gene. , 1996, American journal of medical genetics.

[3]  H. Dietz,et al.  Mutation in fibrillin-1 and the Marfanoid-craniosynostosis (Shprintzen-Goldberg) syndrome , 1996, Nature Genetics.

[4]  J. Newsom-Davis* Professor Anita Harding , 1996 .

[5]  R E Pyeritz,et al.  Fifteen novel FBN1 mutations causing Marfan syndrome detected by heteroduplex analysis of genomic amplicons. , 1995, American journal of human genetics.

[6]  D. Milewicz,et al.  A mutation in FBN1 disrupts profibrillin processing and results in isolated skeletal features of the Marfan syndrome. , 1995, The Journal of clinical investigation.

[7]  C. Price,et al.  Recurrent mis-splicing of fibrillin exon 32 in two patients with neonatal Marfan syndrome. , 1995, Human molecular genetics.

[8]  L. Peltonen,et al.  A compound-heterozygous Marfan patient: two defective fibrillin alleles result in a lethal phenotype. , 1994, American journal of human genetics.

[9]  C. Hayward,et al.  A novel mutation in the fibrillin gene (FBN1) in familial arachnodactyly. , 1994, Molecular and cellular probes.

[10]  L. Peltonen,et al.  An extra cysteine in one of the non-calcium-binding epidermal growth factor-like motifs of the FBN1 polypeptide is connected to a novel variant of Marfan syndrome. , 1994, The Journal of clinical investigation.

[11]  H. Dietz,et al.  Substitution of a cysteine residue in a non-calcium binding, EGF-like domain of fibrillin segregates with the Marfan syndrome in a large kindred. , 1994, Human Molecular Genetics.

[12]  B. Sykes,et al.  A new missense mutation of fibrillin in a patient with Marfan syndrome. , 1994, Journal of medical genetics.

[13]  D. Milewicz,et al.  Severe neonatal Marfan syndrome resulting from a de novo 3-bp insertion into the fibrillin gene on chromosome 15. , 1994, American journal of human genetics.

[14]  L. Peltonen,et al.  A novel mutation of the fibrillin gene causing ectopia lentis. , 1994, Genomics.

[15]  C. Hayward,et al.  Two novel mutations and a neutral polymorphism in EGF-like domains of the fibrillin gene (FBN1): SSCP screening of exons 15-21 in Marfan syndrome patients. , 1994, Human molecular genetics.

[16]  U. Francke,et al.  Mutation screening of complete fibrillin-1 coding sequence: report of five new mutations, including two in 8-cysteine domains. , 1993, Human molecular genetics.

[17]  B. Sykes,et al.  Genomic organization of the sequence coding for fibrillin, the defective gene product in Marfan syndrome. , 1993, Human molecular genetics.

[18]  H. Dietz,et al.  Four novel FBN1 mutations: significance for mutant transcript level and EGF-like domain calcium binding in the pathogenesis of Marfan syndrome. , 1993, Genomics.

[19]  W. L. Robertson,et al.  Prenatal diagnosis and a donor splice site mutation in fibrillin in a family with Marfan syndrome. , 1993, American journal of human genetics.

[20]  H. Dietz,et al.  Fibrillin binds calcium and is coded by cDNAs that reveal a multidomain structure and alternatively spliced exons at the 5' end. , 1993, Genomics.

[21]  R. Mcinnes,et al.  Biochemical genetics: examples of life after cloning. , 1993, Current opinion in genetics & development.

[22]  B. Sykes,et al.  A novel fibrillin mutation in the Marfan syndrome which could disrupt calcium binding of the epidermal growth factor-like module. , 1993, Human molecular genetics.

[23]  David Valle,et al.  The skipping of constitutive exons in vivo induced by nonsense mutations , 1993, Science.

[24]  L. Peltonen,et al.  Two mutations in Marfan syndrome resulting in truncated fibrillin polypeptides. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[25]  E. Puffenberger,et al.  Marfan phenotype variability in a family segregating a missense mutation in the epidermal growth factor-like motif of the fibrillin gene. , 1992, The Journal of clinical investigation.

[26]  C. Maslen,et al.  Localization of the fibrillin (FBN) gene to chromosome 15, band q21.1. , 1991, Genomics.

[27]  Ada Hamosh,et al.  Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene , 1991, Nature.

[28]  R. Glanville,et al.  Partial sequence of a candidate gene for the Marfan syndrome , 1991, Nature.

[29]  D. Sillence,et al.  International Nosology of Heritable Disorders of Connective Tissue, Berlin, 1986. , 1988, American journal of medical genetics.

[30]  E. Engvall,et al.  Fibrillin, a new 350-kD glycoprotein, is a component of extracellular microfibrils , 1986, The Journal of cell biology.

[31]  Thierry Soussi,et al.  Marfan Database (second edition): software and database for the analysis of mutations in the human FBN1 gene , 1997, Nucleic Acids Res..

[32]  C. Hayward,et al.  Identification of a novel nonsense mutation in the fibrillin gene (FBN1) using nonisotopic techniques , 1994, Human mutation.

[33]  L. Peltonen,et al.  Mutations in the fibrillin gene responsible for dominant ectopia lentis and neonatal Marfan syndrome , 1994, Nature Genetics.

[34]  L. Tsui,et al.  A suggested nomenclature for designating mutations , 1993, Human mutation.

[35]  H. Dietz,et al.  Clustering of fibrillin (FBN1) missense mutations in Marfan syndrome patients at cysteine residues in EGF‐like domains , 1992, Human mutation.